US 9441041
Use of antagonists of the interaction between HIV GP120 and α4β7 integrin
granted A61KA61K2039/505A61K38/12
Quick answer
US patent 9441041 (Use of antagonists of the interaction between HIV GP120 and α4β7 integrin) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/505, A61K38/12, A61K39/3955, A61K45/06